source
- Bristol Myers reports patient death in autoimmune CAR-T trial and explains summer pauseBristol Myers Squibb disclosed that a participant in its autoimmune CAR-T cell therapy study has died. The company said the death occurred during the trial and is under investigation, with details…
- US proposes new biotech investment limits on China, but licensing deals remain allowedThe U.S. Treasury announced a proposal to curb outbound investments in Chinese biotechnology, citing national‑security concerns. The plan would limit U.S. persons from funding certain bio‑derived c…